Cargando…

Post Kala-Azar Dermal Leishmaniasis: Clinical Features and Differential Diagnosis

Post kala-azar dermal leishmaniasis (PKDL) is a mucocutaneous disease usually seen in apparently cured, inadequately treated or untreated cases of visceral leishmaniasis and is endemic to many parts of India, Nepal, Bangladesh, and eastern Africa (Sudan, Ethiopia, Kenya). The disease usually manifes...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Piyush, Chatterjee, Mitali, Das, Nilay Kanti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061484/
https://www.ncbi.nlm.nih.gov/pubmed/33911290
http://dx.doi.org/10.4103/ijd.IJD_602_20
_version_ 1783681576265056256
author Kumar, Piyush
Chatterjee, Mitali
Das, Nilay Kanti
author_facet Kumar, Piyush
Chatterjee, Mitali
Das, Nilay Kanti
author_sort Kumar, Piyush
collection PubMed
description Post kala-azar dermal leishmaniasis (PKDL) is a mucocutaneous disease usually seen in apparently cured, inadequately treated or untreated cases of visceral leishmaniasis and is endemic to many parts of India, Nepal, Bangladesh, and eastern Africa (Sudan, Ethiopia, Kenya). The disease usually manifests as a variable combination of hypopigmented patches, erythematous succulent papulo-plaques, and nodular lesions on the face and upper body and sometimes extending on the extremities, genitalia, and tongue. Atypical morphology and presentations are not uncommon, especially in endemic areas, which include photosensitivity, verrucous, hypertrophic, xanthomatous, and ulcerative lesions. Recognition of spectrum of mucocutaneous changes helps physicians in early initiation of treatment and in reducing disease transmission in the community. The differential diagnosis depends on the pattern of manifestations, but lepromatous leprosy is the closest mimicker. Since PKDL does not cause significant morbidity, at least initially, but the affected patients continue to act as a reservoir of the disease, active case detection is required to identify cases early to control the disease transmission in the community.
format Online
Article
Text
id pubmed-8061484
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-80614842021-04-27 Post Kala-Azar Dermal Leishmaniasis: Clinical Features and Differential Diagnosis Kumar, Piyush Chatterjee, Mitali Das, Nilay Kanti Indian J Dermatol IJD Symposium Post kala-azar dermal leishmaniasis (PKDL) is a mucocutaneous disease usually seen in apparently cured, inadequately treated or untreated cases of visceral leishmaniasis and is endemic to many parts of India, Nepal, Bangladesh, and eastern Africa (Sudan, Ethiopia, Kenya). The disease usually manifests as a variable combination of hypopigmented patches, erythematous succulent papulo-plaques, and nodular lesions on the face and upper body and sometimes extending on the extremities, genitalia, and tongue. Atypical morphology and presentations are not uncommon, especially in endemic areas, which include photosensitivity, verrucous, hypertrophic, xanthomatous, and ulcerative lesions. Recognition of spectrum of mucocutaneous changes helps physicians in early initiation of treatment and in reducing disease transmission in the community. The differential diagnosis depends on the pattern of manifestations, but lepromatous leprosy is the closest mimicker. Since PKDL does not cause significant morbidity, at least initially, but the affected patients continue to act as a reservoir of the disease, active case detection is required to identify cases early to control the disease transmission in the community. Wolters Kluwer - Medknow 2021 /pmc/articles/PMC8061484/ /pubmed/33911290 http://dx.doi.org/10.4103/ijd.IJD_602_20 Text en Copyright: © 2021 Indian Journal of Dermatology https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle IJD Symposium
Kumar, Piyush
Chatterjee, Mitali
Das, Nilay Kanti
Post Kala-Azar Dermal Leishmaniasis: Clinical Features and Differential Diagnosis
title Post Kala-Azar Dermal Leishmaniasis: Clinical Features and Differential Diagnosis
title_full Post Kala-Azar Dermal Leishmaniasis: Clinical Features and Differential Diagnosis
title_fullStr Post Kala-Azar Dermal Leishmaniasis: Clinical Features and Differential Diagnosis
title_full_unstemmed Post Kala-Azar Dermal Leishmaniasis: Clinical Features and Differential Diagnosis
title_short Post Kala-Azar Dermal Leishmaniasis: Clinical Features and Differential Diagnosis
title_sort post kala-azar dermal leishmaniasis: clinical features and differential diagnosis
topic IJD Symposium
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061484/
https://www.ncbi.nlm.nih.gov/pubmed/33911290
http://dx.doi.org/10.4103/ijd.IJD_602_20
work_keys_str_mv AT kumarpiyush postkalaazardermalleishmaniasisclinicalfeaturesanddifferentialdiagnosis
AT chatterjeemitali postkalaazardermalleishmaniasisclinicalfeaturesanddifferentialdiagnosis
AT dasnilaykanti postkalaazardermalleishmaniasisclinicalfeaturesanddifferentialdiagnosis